AI Reputation Analysis and Signal Evaluation – LYNPARZA (AstraZeneca)

B
Reputation Level
Medical Devices, Pharma & Biotech
59.3 Avg Reputation

Based on 784 businesses audited.

Brand AI Reputation

Medical Devices, Pharma & Biotech Reputation: LYNPARZA (AstraZeneca) (lynparza.com)

https://lynparza.com 📍 Industry: Medical Devices, Pharma & Biotech
75 Reputation / 100

This is a high-substance, low-fluff pharmaceutical portal where every claim is constrained by legal safety requirements. It is a functional medical utility, not a marketing experiment, resulting in a very low BS score of 25.

Info Density Power-words vs. Substance ratio.
24 80% Reputation
View evidence →
Semantic Coherence Homepage promise vs. Sub-page reality.
18 90% Reputation
View evidence →
Trust & Proof Verifiable evidence vs. Trust Theatre.
12 60% Reputation
View evidence →
Commodity Fingerprint Detection of industry clichés/templates.
8 53% Reputation
View evidence →
Identity & Authority Expert verifiability & Schema depth.
13 87% Reputation
View evidence →

Medical Devices, Pharma & Biotech Reputation: LYNPARZA (AstraZeneca) (lynparza.com)

Reputation: 75 / 100

The website perfectly aligns with the Pharma and Biotech industry category. The content is heavily saturated with regulatory-required language, including Important Safety Information (ISI) and specific clinical indications for oncology medications.

“The score of 75 is primarily driven by the trust and proof pillar (8) due to the lack of external verification for patient stories and the commodity fingerprint (7) of the site's structural template. Information density and identity are extremely strong, preventing the score from rising into the moderate or high BS ranges.”

Verified Analysis Date: May 31, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result